Pharmaceutical Excipients Market, By Product (Organic and Inorganic), By Functionality, By Formulation, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Pharmaceutical Excipients Market size was valued at USD 10,237.43 Million in 2024, expanding to a CAGR of 6.96% from 2025 to 2032.
Pharmaceutical excipients are non-active compounds included in drug formulations alongside the active pharmaceutical ingredient (API). These substances play a crucial role in the drug\'s overall performance, including facilitating drug absorption, improving shelf-life stability, enhancing the taste, and supporting the manufacturing process. They ensure that the drug is effective, safe, and suitable for use by patients.
Pharmaceutical Excipients Market- Market Dynamics
Ø Increasing Demand for Novel Drug Delivery Systems and Biopharmaceuticals to Drive Market Growth
The pharmaceutical excipients market is witnessing robust growth, fueled by a combination of factors including the expansion of the global pharmaceutical sector, innovations in drug formulation, and the rising adoption of advanced drug delivery systems (ADDS). Traditional drug delivery methods are gradually being replaced by more sophisticated systems like controlled-release, sustained-release, and targeted drug delivery systems. These advanced systems require specialized excipients that support optimal drug release, enhance stability, and ensure the therapeutic effectiveness of the drug. Polymers, lipids, and other excipients play a vital role in the development of controlled-release formulations, which not only improve drug bioavailability but also reduce the frequency of dosing. The pharmaceutical manufacturing industry is also seeing rapid growth in emerging economies like China, India, and Brazil. These countries benefit from cost-effective production, government incentives, and expanding healthcare infrastructure. In India, for example, the pharmaceutical industry is projected to reach $65 billion by 2024, driven by affordable production costs and a booming export market.
The growing demand for biopharmaceuticals is another key driver for the excipients market. Excipients such as sucrose, trehalose, and mannitol are integral in maintaining the stability of freeze-dried biologics, which are crucial for vaccines and other biologic drugs. With the global biopharmaceutical market expected to exceed $400 billion by 2026, the demand for excipients tailored for these complex formulations is expected to rise significantly. Furthermore, regulatory bodies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the International Council for Harmonisation (ICH) impose rigorous standards on drug formulations, safety, and efficacy. The FDA alone approved 46 new molecular entities in 2022, underscoring the growing importance of high-quality, compliant excipients that can meet the stringent safety and stability standards required for global market approval. To comply with these regulations, pharmaceutical companies are increasingly focusing on the development and use of excipients that enhance the safety, stability, and overall quality of their products.
Pharmaceutical Excipients Market- Segmentation Analysis:
The Global Pharmaceutical Excipients Market is segmented on the basis of Product, Functionality, Formulation, Application, and Region.
Based on product type, the market is divided into two categories: organic and inorganic excipients. The organic segment leads the market due to the increasing demand for biological drugs and novel drug delivery systems. Organic excipients, often derived from natural sources, play a key role in the development of biologics, which have become more prominent in modern therapeutics. According to the U.S. Food and Drug Administration (FDA), the approval rate of biologic drugs has seen a 25% annual increase over the past five years, highlighting the growing reliance on organic excipients. As the demand for biologics rises, the organic excipient segment is expected to continue to dominate the market.
The market is also segmented based on functionality into seven categories: fillers, binders, coating agents, colorants, disintegrants, lubricants & glidants, and others. Among these, the lubricants and glidants segment is expected to hold the largest share due to their high demand in oral dosage formulations. These excipients are essential for enhancing the flow properties of powdered drug formulations and ensuring consistent tablet and capsule manufacturing. The U.S. National Institute for Pharmaceutical Technology and Education (NIPTE) reports that over 75% of drugs in the U.S. are delivered via oral dosage forms, which increases the need for lubricants and glidants. Their role in improving manufacturing efficiency and product quality contributes significantly to their market dominance.
Regarding formulation types, the market is divided into oral, topical, parenteral, and others. The oral formulation segment is projected to hold the largest share due to the extensive use and efficacy of oral dosage forms against a wide range of ailments. Oral medications remain the most commonly prescribed form of treatment due to their convenience, cost-effectiveness, and patient preference. The U.S. Centers for Disease Control and Prevention (CDC) reports that nearly 80% of adults in the U.S. use oral prescription medications, reinforcing the demand for excipients in oral formulations. This widespread use of oral drugs continues to drive the growth of the excipients market in the oral formulation category.
The market is further segmented based on application into stabilizers, taste masking, and other categories. The stabilizers segment holds the highest share of the application market, driven by the increasing demand for high-quality excipients in generic drug production. Stabilizers play a critical role in ensuring the stability and shelf-life of pharmaceutical products, which is crucial as the generic drug market continues to expand. According to the U.S. Generic Pharmaceutical Association (GPhA), generic drugs accounted for 90% of all prescriptions filled in the U.S. in 2023, significantly boosting the need for stabilizers in these formulations. As generic drugs grow in popularity, the demand for excipients that ensure the integrity and quality of these drugs is expected to drive further growth in the stabilizer segment.
Pharmaceutical Excipients Market- Geographical Insights
The global pharmaceutical excipients market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region showing distinct growth drivers. North America remains the dominant player in the pharmaceutical excipients market, particularly the U.S., which is home to a large pharmaceutical sector. The U.S. is not only the leading producer of generic drugs but also has a thriving biopharmaceutical industry, contributing to the growing demand for excipients. According to the U.S. Department of Commerce, the U.S. pharmaceutical industry was valued at $330 billion in 2022, and this is expected to continue driving the demand for excipients as drug formulations become more complex. Europe leads in innovative drug formulations, especially in the biopharmaceutical and vaccine sectors, both of which require highly specialized excipients. The region’s aging population also plays a significant role in the increased demand for pharmaceutical excipients, particularly for oral drug formulations that target chronic diseases. According to the European Commission, Europe’s pharmaceutical market is expected to reach €320 billion by 2025, driven by innovations in drug delivery systems and an aging demographic that requires more specialized medications.
In the Asia-Pacific region, countries like India and China are emerging as global hubs for pharmaceutical contract manufacturing. This is due to their lower production costs and an increasingly sophisticated pharmaceutical manufacturing infrastructure. China’s National Development and Reform Commission (NDRC) reported that the country’s pharmaceutical industry has been growing at a compound annual growth rate (CAGR) of 6.5% over the past five years. This has spurred significant demand for excipients, as the region scales up production to meet both domestic and international market needs. Additionally, India is expected to become the third-largest pharmaceutical market globally by 2030, further fueling the demand for excipients. The Middle East and Africa, while still a smaller market compared to other regions, are experiencing increasing investments in pharmaceutical manufacturing and drug production, especially in countries like Saudi Arabia and South Africa. This is driving demand for excipients as these countries strive to meet both local and international pharmaceutical standards.
Pharmaceutical Excipients Market- Competitive Landscape:
The pharmaceutical excipients market is highly competitive, with a diverse range of global and regional players focused on producing and supplying excipients critical to drug formulation. These excipients enhance drug stability, bioavailability, and overall performance. Market participants are increasingly prioritizing the development of excipients that cater to various drug delivery systems, including controlled-release formulations, bioavailability enhancers, and solubilizers. To maintain a competitive edge, companies are investing heavily in research and development (R&D) to innovate and create new excipients that can enhance drug performance. The demand for excipients enabling sustained-release, controlled-release, and improved bioavailability is growing, pushing companies to provide customized solutions to meet the needs of the pharmaceutical industry.
Recent Developments:
v 2023: BASF partnered with Croda International Plc to develop and commercialize new excipients aimed at improving drug delivery, particularly for oral and parenteral formulations.
v 2024: Roquette Frères focused on the development of plant-based excipients to meet the increasing demand for natural ingredients, aligning with growing consumer preferences for eco-friendly and sustainable pharmaceutical products.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET KEY PLAYERS
Ø Dow Inc.
Ø Evonik Industries AG
Ø BASF SE
Ø Lubrizol Corporation
Ø FMC Corporation
Ø Roquette Frères
Ø Sinopharm Group Co., Ltd.
Ø Wacker Chemie AG
Ø Shin-Etsu Chemical Co., Ltd.
Ø InnoBio Limited
Ø Ashland Global Holdings Inc.
Ø Cargill, Inc.
Ø JRS PHARMA GmbH & Co. KG
Ø Mitsubishi Chemical Corporation
Ø ARCH Chemicals, Inc.
Ø Others
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032
Ø Organic
Ø Inorganic
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY- MARKET ANALYSIS, 2019-2032
Ø Fillers
Ø Binders
Ø Coating agents
Ø Colorants
Ø Disintegrants
Ø Lubricants & glidants
Ø Others
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION- MARKET ANALYSIS, 2019-2032
Ø Oral
Ø Topical
Ø Parenteral
Ø Others
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
Ø Stabilizers
Ø Taste masking
Ø Others
GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Pharmaceutical Excipients Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Pharmaceutical Excipients Market Snippet by Product
2.1.2. Pharmaceutical Excipients Market Snippet by Functionality
2.1.3. Pharmaceutical Excipients Market Snippet by Formulation
2.1.4. Pharmaceutical Excipients Market Snippet by Application
2.1.5. Pharmaceutical Excipients Market Snippet by Country
2.1.6. Pharmaceutical Excipients Market Snippet by Region
2.2. Competitive Insights
3. Pharmaceutical Excipients Key Market Trends
3.1. Pharmaceutical Excipients Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Pharmaceutical Excipients Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Pharmaceutical Excipients Market Opportunities
3.4. Pharmaceutical Excipients Market Future Trends
4. Pharmaceutical Excipients Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Pharmaceutical Excipients Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Pharmaceutical Excipients Market Landscape
6.1. Pharmaceutical Excipients Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Pharmaceutical Excipients Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Organic
7.1.3. Inorganic
8. Pharmaceutical Excipients Market – By Functionality
8.1. Overview
8.1.1. Segment Share Analysis, By Functionality, 2024 & 2032 (%)
8.1.2. Fillers
8.1.3. Binders
8.1.4. Coating agents
8.1.5. Colorants
8.1.6. Disintegrants
8.1.7. Lubricants & glidants
8.1.8. Others
9. Pharmaceutical Excipients Market – By Formulation
9.1. Overview
9.1.1. Segment Share Analysis, By Formulation, 2024 & 2032 (%)
9.1.2. Oral
9.1.3. Topical
9.1.4. Parenteral
9.1.5. Others
10. Pharmaceutical Excipients Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Functionality, 2024 & 2032 (%)
10.1.2. Stabilizers
10.1.3. Taste masking
10.1.4. Others
11. Pharmaceutical Excipients Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Pharmaceutical Excipients Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Pharmaceutical Excipients Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Pharmaceutical Excipients Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Pharmaceutical Excipients Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Pharmaceutical Excipients Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Functionality, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Pharmaceutical Excipients Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Dow Inc.
12.2.2. Evonik Industries AG
12.2.3. BASF SE
12.2.4. Lubrizol Corporation
12.2.5. FMC Corporation
12.2.6. Roquette Frères
12.2.7. Sinopharm Group Co., Ltd.
12.2.8. Wacker Chemie AG
12.2.9. Shin-Etsu Chemical Co., Ltd.
12.2.10. InnoBio Limited
12.2.11. Ashland Global Holdings Inc.
12.2.12. Cargill, Inc.
12.2.13. JRS PHARMA GmbH & Co. KG
12.2.14. Mitsubishi Chemical Corporation
12.2.15. ARCH Chemicals, Inc.
12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
